Charles Schwab’s Adaptive Biotechnologies ADPT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$15.9M Sell
1,145,682
-27,853
-2% -$444K ﹤0.01% 1868
2025
Q4
$19.1M Buy
1,173,535
+20,974
+2% +$342K ﹤0.01% 1775
2025
Q3
$17.2M Buy
1,152,561
+110,111
+11% +$1.34M ﹤0.01% 1829
2025
Q2
$12.1M Buy
1,042,450
+119,708
+13% +$1.09M ﹤0.01% 1915
2025
Q1
$6.86M Sell
922,742
-33,832
-4% -$260K ﹤0.01% 2137
2024
Q4
$5.73M Buy
956,574
+39,831
+4% +$220K ﹤0.01% 2278
2024
Q3
$4.69M Buy
916,743
+10,262
+1% +$44.7K ﹤0.01% 2405
2024
Q2
$3.28M Buy
906,481
+36,699
+4% +$116K ﹤0.01% 2530
2024
Q1
$2.79M Buy
869,782
+113,850
+15% +$441K ﹤0.01% 2501
2023
Q4
$3.7M Sell
755,932
-103,135
-12% -$471K ﹤0.01% 2429
2023
Q3
$4.68M Buy
859,067
+21,177
+3% +$140K ﹤0.01% 2291
2023
Q2
$5.62M Buy
837,890
+14,571
+2% +$108K ﹤0.01% 2198
2023
Q1
$7.27M Sell
823,319
-1,080
-0.1% -$9.52K ﹤0.01% 2027
2022
Q4
$6.3M Buy
824,399
+26,052
+3% +$203K ﹤0.01% 2093
2022
Q3
$5.68M Sell
798,347
-295,271
-27% -$2.78M ﹤0.01% 2148
2022
Q2
$8.85M Buy
1,093,618
+233,850
+27% +$2.06M ﹤0.01% 1906
2022
Q1
$11.9M Buy
859,768
+19,097
+2% +$300K ﹤0.01% 1849
2021
Q4
$23.6M Buy
840,671
+19,051
+2% +$584K 0.01% 1452
2021
Q3
$27.9M Buy
821,620
+195,751
+31% +$7.08M 0.01% 1293
2021
Q2
$25.6M Buy
625,869
+22,562
+4% +$877K 0.01% 1388
2021
Q1
$24.3M Buy
603,307
+51,881
+9% +$2.81M 0.01% 1378
2020
Q4
$32.6M Buy
551,426
+10,575
+2% +$545K 0.01% 1043
2020
Q3
$26.3M Buy
540,851
+382,289
+241% +$16.1M 0.01% 1029
2020
Q2
$7.67M Buy
158,562
+12,206
+8% +$445K ﹤0.01% 1799
2020
Q1
$4.07M Buy
146,356
+54,460
+59% +$1.52M ﹤0.01% 1931
2019
Q4
$2.75M Buy
91,896
+1,795
+2% +$51.5K ﹤0.01% 2315
2019
Q3
$2.79M Buy
+90,101
New +$3.68M ﹤0.01% 2261

Other funds holding ADPT